Filana Therapeutics, Inc.
- FLNA
- NASDAQ
- Biotechnology
- Alzheimer's Disease R&D
- Diagnostics
$0.68
Today −3.06%Quote Oct 19, 2026, 08:00 PM UTC
−6.06%over the last month
Max drawdown −33.8%From 1-month high −33.8%3 months −32.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Filana Therapeutics
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
19
Market value
$32.9M
Quote Oct 19
Floor
$0.67
1.7% below price
Resistance
$0.74
8.5% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about FLNAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free